Tutte le immagini(1)

Documenti

CdO/CdA

1A02450

USP

2-Dechloro Aripiprazole

Name: 2-Dechloro Aripiprazole
Brand: USP

Pharmaceutical Analytical Impurity (PAI)

Sinonimo/i:

7-[4-[4-(3-Chlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydroquinolin-2(1H)-one, 2-Deschloro-aripiprazole

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):

C₂₃H₂₈ClN₃O₂

Numero CAS:

203395-82-8

Peso molecolare:

413.94

Codice UNSPSC:

41116100

NACRES:

NA.24

Prodotti consigliati

Slide 1 of 10

1 of 10

Y0001650

Aripiprazole impurity F

Supelco

PHR1182

Papaverine hydrochloride

Y0000478

Granisetron impurity B

BP734

Acido trans-4-(amminometil)cicloesanocarbossilico

Supelco

PHR3274

4-Methyl-2-pentanol

USP

1643565

Temozolomide Related Compound B

USP

1643554

Temozolomide Related Compound A

Sigma-Aldrich

D161292

2-Amino-6-methylheptane

Sigma-Aldrich

185841

Dicyclohexylamine

USP

1414025

Methotrexate Related Compound B

Grado

pharmaceutical analytical impurity (PAI)

agenzia

USP

Famiglia di API

aripiprazole

Produttore/marchio commerciale

USP

applicazioni

pharmaceutical

Formato

neat

Temperatura di conservazione

2-8°C

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Analytical Reference Standards

Pharmacopeia & Metrological Institute Standards

Descrizione generale

2-Dechloro Aripiprazole is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Aripiprazole.

For more information about this PAI, visit here.

Applicazioni

2-Dechloro Aripiprazole (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Caratteristiche e vantaggi

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Risultati analitici

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Altre note

Sales restrictions may apply.

Pittogrammi

GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302,H413

Consigli di prudenza

P264 - P270 - P273 - P301 + P312 - P501

Classi di pericolo

Acute Tox. 4 Oral - Aquatic Chronic 4

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)